PD-L1 and Lung Cancer Research: Pathways to Promising Immunotherapies
admin April 24, 2013Lung cancer remains a leading cause of cancer-related death worldwide due to its oft advanced stage at discovery, in combination with its difficult-to-treat and complex nature. Non-small cell lung cancer (NSCLC), for example, classifies some 85 per cent of lung cancer cases, and tumors in this category can harbor mutations in any of several… Continue Reading »